To the Editor The Aldo-DHF trial1 (similar
to other trials in HF with preserved EF2,3) failed
to demonstrate a benefit from neurohormonal antagonism. We are concerned about the inclusion
criteria and power of the study.
Lund LH, Ståhlberg M. Aldosterone Inhibition in Patients With Heart Failure With Preserved Ejection
Fraction. JAMA. 2013;310(2):205. doi:10.1001/jama.2013.7967
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: